Correlation Between Adial Pharmaceuticals and Galera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Adial Pharmaceuticals and Galera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adial Pharmaceuticals and Galera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adial Pharmaceuticals and Galera Therapeutics, you can compare the effects of market volatilities on Adial Pharmaceuticals and Galera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adial Pharmaceuticals with a short position of Galera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adial Pharmaceuticals and Galera Therapeutics.
Diversification Opportunities for Adial Pharmaceuticals and Galera Therapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Adial and Galera is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Adial Pharmaceuticals and Galera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Galera Therapeutics and Adial Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adial Pharmaceuticals are associated (or correlated) with Galera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Galera Therapeutics has no effect on the direction of Adial Pharmaceuticals i.e., Adial Pharmaceuticals and Galera Therapeutics go up and down completely randomly.
Pair Corralation between Adial Pharmaceuticals and Galera Therapeutics
If you would invest 100.00 in Adial Pharmaceuticals on August 31, 2024 and sell it today you would lose (1.00) from holding Adial Pharmaceuticals or give up 1.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 4.55% |
| Values | Daily Returns |
Adial Pharmaceuticals vs. Galera Therapeutics
Performance |
| Timeline |
| Adial Pharmaceuticals |
| Galera Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Adial Pharmaceuticals and Galera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adial Pharmaceuticals and Galera Therapeutics
The main advantage of trading using opposite Adial Pharmaceuticals and Galera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adial Pharmaceuticals position performs unexpectedly, Galera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galera Therapeutics will offset losses from the drop in Galera Therapeutics' long position.| Adial Pharmaceuticals vs. Transcode Therapeutics | Adial Pharmaceuticals vs. Aditxt Inc | Adial Pharmaceuticals vs. Reviva Pharmaceuticals Holdings | Adial Pharmaceuticals vs. Avenue Therapeutics |
| Galera Therapeutics vs. Mereo BioPharma Group | Galera Therapeutics vs. Terns Pharmaceuticals | Galera Therapeutics vs. PDS Biotechnology Corp | Galera Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |